Rating: 4.8 out of 5 (99 ratings)
Board certified in internal medicine, hematology and medical oncology, Dr. Ardeshir-Larijani`s primary clinical focus is thoracic oncology including lung cancer, mesothelioma and thymic tumors.
Dr. Ardeshir-Larijani is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. She is also one of the ECOG-ACRIN trial investigator.
Dr. Ardeshir-Larijani's scholarly and research activities are on new target discovery and defining an immune resistance mechanism in lung cancer. She also has clinical and research interests in thymic epithelial tumors.
|
|
|
|
Dr. Ardeshir-Larijani has been published in several leading journals including the New England Journal of Medicine, Clinical Lung Cancer, JCO-Precision Oncology, JCO-Oncology Practice, Nature Communications, Cancer Letters and Nature Review Clinical Oncology. She has also appeared as a subject matter expert in various press outlets, including ASCO Daily News.
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
Cancer letters |
M Khorrami, P Mutha, C Barrera, VS Viswanathan, F Ardeshir-Larijani, P Jain, K Higgins, A Madabhushi | 09/28/2025 |
|
JCO oncology practice |
N Dizman, Z Bakouny, T Haykal, I Riano, A Desai, A Butt, A Basu, D Zhao, E Saad, RM Saliby, R Gosain, R Gosain, F Ardeshir, L Deng, L Matt-Amaral, K Arnaoutakis, T Bekaii-Saab, R Manochakian, A Marshall, P Forde, M Murphy, V Subbiah, M Chavez-MacGregor, TK Owonikoko, G Lopes, C Aggarwal, AI Lee, TK Choueiri | 03/01/2025 |
|
The MARIPOSA trials - implications for the treatment of EGFR-mutant NSCLC. Nature reviews. Clinical oncology |
F Ardeshir-Larijani, SS Ramalingam | 11/01/2024 |
|
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency. The New England journal of medicine |
A Cheng, A Kashyap, H Salvator, LB Rosen, D Colby, F Ardeshir-Larijani, PJ Loehrer, L Ding, SO Lugo Reyes, S Riminton, M Ballman, JM Rocco, BE Marciano, AF Freeman, SK Browne, AP Hsu, A Zelazny, A Rajan, I Sereti, CS Zerbe, MS Lionakis, SM Holland | 03/21/2024 |
|
Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report. Clinical lung cancer |
F Ardeshir-Larijani, R Maniar, S Goyal, PJ Loehrer, T Hou, V DeBrock, H Mesa | 03/01/2024 |
|
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology |
F Ardeshir-Larijani, BP Schneider, SK Althouse, M Radovich, A Masood, F Perna, H Salman, PJ Loehrer | 02/01/2023 |
|
Clinical lung cancer |
F Ardeshir-Larijani, SK Althouse, T Leal, LE Feldman, TA Hejleh, M Patel, RD Gentzler, AR Miller, NH Hanna | 11/01/2022 |
Dr. Ardeshir-Larijani is the recipient of the following awards and honors:
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.9 |
| Provider showed concern |
| 4.9 |
| Provider explained things clearly |
| 4.8 |
| Provider discussed treatment options |
| 4.8 |
| Provider included you in decisions |
| 4.8 |
| Likelihood of recommending this provider |
|
07/27/2025 |
Better informed by this amazing Dr than when I arrived! |
|
03/28/2025 |
Dr. Adeshir was caring, informative and professional. She is a fantastic physician |
|
03/08/2025 |
Again, Dr. Ardeshir Larijani provided effective and outstanding service to me. |
|
03/05/2025 |
Dr. Ardeshir is a very caring and knowledgeable doctor. |
|
01/16/2025 |
Would whole heartedly recommend Dr. Ardeshir. |
|
01/15/2025 |
Dr. Larijani is a great listener and follows up on my concerns. |
|
12/24/2024 |
Dr. Ardeshir has gone out of her way to help me navigate through my health issues, expand on any questions I may have had, and select the best possible physicians and doctors as needed to continue with. Dr Ardeshir is a quality professional and top notch in my book. |
|
12/04/2024 |
Dr. Ardeshir is excellent! |
|
11/09/2024 |
Dr. Ardeshir is great. |
|
10/28/2024 |
Very good. Excellent attention |
|
10/21/2024 |
Sometimes hard to understand her, but we got through it |
|
09/07/2024 |
Like my Dr very much |
|
08/31/2024 |
Dr.let me know what I needed to do. Order order the test I need to get. |
|
08/31/2024 |
Things and treatment were explained in detail |
|
08/10/2024 |
The provider treated me like a case and not a human being. Provider never showed compassion . Provider never asked how I was feeling and was pushing clinical trials . |
|
07/01/2024 |
More details on treatment plan and the length treatment. Also information on possible side effects. |
|
06/09/2024 |
One of the main reasons I'm sticking with emory is because of your doctors. They are what's good about emory |
|
06/08/2024 |
Good |
|
03/03/2024 |
Dr. Fatima is the best! Very caring and kind, very genuine! |
|
03/02/2024 |
Dr. Larijani is as good as it gets. She provides excellent personalized care. |
|
02/24/2024 |
Doctor was very knowledgeable, kind & courteous. Listened well to me & provided excellent answers to all of my questions. She laid out a game plan to address my issues & spent a good amount of time with me. I liked her very much. |
|
11/13/2023 |
I finally feel like I have a physician at Winship who Is listening and proactive with solutions. It helps that she has a thinking heart with a beautiful bedside manner. She has excellent communication regarding the scan and the ability to articulate in a way that lets you know you have a medical partnership with care. |
|
10/30/2023 |
Very hood bedside manner. Answered all questions |
